Comparison between Beta Drugs IPO and Tirupati Forge IPO.
Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while Tirupati Forge IPO is a SME Fixed Price proposed to list at NSE SME.
| Beta Drugs IPO | Tirupati Forge IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Pantomath Stock Brokers Pvt.Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the Tirupati Forge IPO is up to ₹4.95 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Tirupati Forge IPO is ₹29.00 per share.
| Beta Drugs IPO | Tirupati Forge IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Final) | ₹85.00 per share | ₹29.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 1600 shares | 4000 shares |
| Fresh Issue Size | 21,66,400 shares | 17,08,000 shares |
| Fresh Issue Size (Amount) | up to ₹18.41 Cr | up to ₹4.95 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,66,400 shares | 17,08,000 shares |
| Issue Size Total (Amount) | up to ₹18.41 Cr | up to ₹4.95 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while Tirupati Forge IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and Tirupati Forge IPO is Oct 04, 2017, and Oct 04, 2017, respectively.
| Beta Drugs IPO | Tirupati Forge IPO | |
|---|---|---|
| Issue Open | Sep 29, 2017 | Sep 29, 2017 |
| Issue Close | Oct 04, 2017 | Oct 04, 2017 |
| Basis Of Allotment (Tentative) | Oct 10, 2017 | Oct 09, 2017 |
| Listing date (Tentative) | Oct 12, 2017 | Oct 12, 2017 |
Beta Drugs IPO P/E ratio is , as compared to Tirupati Forge IPO P/E ratio of .
| Beta Drugs IPO | Tirupati Forge IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 93.78% | 98.72% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.89% | 68.15% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹73.52 Cr. | ₹16.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in Tirupati Forge IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Beta Drugs IPO and 0 shares in Tirupati Forge IPO.
| Beta Drugs IPO | Tirupati Forge IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 1,29,600 shares | 92,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 10,83,200 shares | 8,54,000 shares |
| RII | 10,83,200 shares | 8,54,000 shares |
| Employee | 0 shares | 0 shares |
| Total | 21,66,400 shares | 17,08,000 shares |
Beta Drugs IPO subscribed 18.97x in total, whereas Tirupati Forge IPO subscribed 6.94x.
| Beta Drugs IPO | Tirupati Forge IPO | |
|---|---|---|
| NII (times) | 29.93x | 3.56x |
| RII (times) | 8.00x | 10.32x |
| Total (times) | 18.97x | 6.94x |
